Thermo Fisher synergy Leverage the incumbent relationship with Thermo Fisher Scientific and position Linkage Biosciences’ HLA typing and antibody detection offerings as an integrated transplant diagnostics solution within Thermo Fisher’s broader ecosystem to cross-sell instrumentation, software, and services.

SMB niche focus Target transplant laboratories and clinics with limited internal capacity, emphasizing turnkey workflows, automation software, and compatible technologies (serology, ELISA, flow cytometry, SSP, rSSO, SBT, PCR, NGS) to reduce manual labor and increase throughput.

Expansion potential Highlight opportunities for portfolio expansion through complementary tools and services in lab automation and data analytics, leveraging Thermo Fisher’s scale to offer bundled solutions and support for new geographies or clinical applications.

Financial signals With reported revenue in the lower mid-range and partnerships within a large corporate group, pursue value-focused proposals that emphasize ROI, cost-per-test reductions, and scalable capacity to align with potential customers’ budget cycles.

Competitive positioning Differentiate from peers by stressing the integrated, end-to-end transplant diagnostics capability under a global leader, while offering flexible technologies across multiple platforms and robust customer support to win labs seeking reliability and breadth.